Doctronic Secures $40M Series B, Expands AI-Driven Medical Practice Across US
March 24, 2026
Doctronic, the first AI-enabled medical practice authorized to operate in the United States, announced a $40 million Series B led by Abstract and Lightspeed Venture Partners, bringing total funding to over $65 million as it scales under a year.
The funding underscores strong investor confidence in AI-driven medical administration and the company’s push to become the digital front door for care.
Doctronic is pursuing regulatory discussions beyond Utah and has established partnerships with major health systems, third-party administrators, and self-insured employers to broaden its AI-prescribing capabilities.
The company emphasizes autonomous AI that performs dozens of safety checks per prescription renewal, achieving a 99.2% treatment alignment rate, with physicians available for complex cases or video visits for a copay.
Leadership stresses durable consumer scale, real clinical workflow integration, and a safety- and outcomes-focused model, positioning Doctronic as infrastructure and a digital front door for care.
Doctronic now serves health systems, payers, and employers through cobranded partnerships while maintaining a direct-to-consumer platform used by millions nationwide.
The piece is presented as sponsor-filled tech/news content, which may influence depth and sourcing of the narrative.
The platform runs its own clinical practice licensed in all 50 states, is HIPAA-compliant, and offers 24/7 access with seamless integration to patient records, medication history, and drug interaction data through established health information networks.
In December 2025, Doctronic became the first AI-native platform to autonomously renew prescriptions within Utah’s AI Learning Lab regulatory sandbox, signaling regulatory validation of its clinical rigor.
Proceeds will fund hiring and technology scaling, with plans to roll out platform versions with digital health partners, health systems, and payers.
The round and pilots point to broader industry interest in automating routine pharmaceutical processes to boost efficiency and ease clinician workload.
Doctronic uses a collective intelligence architecture with specialized AI agents under physician oversight and offers unique AI medical malpractice insurance for autonomous AI practice.
Summary based on 3 sources
Get a daily email with more Tech stories
Sources

STAT • Mar 23, 2026
Doctronic raises $40 million as race to apply AI in clinical care heats up